UOC
SNY icon

UBS O'Connor’s Sanofi SNY Stock Holding History

UBS O'Connor’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,144
Closed -$1.97M – 564
2024
Q3 		$1.97M Sell
34,144
-32,206
-49% -$1.74M 0.05% 175
2024
Q2 		$3.22M Buy
66,350
+33,867
+104% +$1.63M 0.09% 145
2024
Q1 		$1.58M Sell
32,483
-90,940
-74% -$4.44M 0.05% 224
2023
Q4 		$6.14M Buy
123,423
+16,492
+15% +$806K 0.19% 61
2023
Q3 		$5.74M Buy
106,931
+15,000
+16% +$800K 0.1% 103
2023
Q2 		$4.96M Buy
91,931
+9,283
+11% +$499K 0.1% 109
2023
Q1 		$4.5M Buy
82,648
+3,936
+5% +$191K 0.11% 152
2022
Q4 		$3.81M Sell
78,712
-50,364
-39% -$2.21M 0.07% 264
2022
Q3 		$4.91M Buy
129,076
+34,803
+37% +$1.55M 0.06% 218
2022
Q2 		$4.72M Buy
+94,273
New +$5M 0.05% 339

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS O'Connor's SNY Position: Q4 2024 in Review

UBS O'Connor sold out of Sanofi (SNY) in Q4 2024, closing a stake of 34,144 shares — an estimated $1.97M sold.

UBS O'Connor first reported a position in SNY in Q2 2022 and held it in 10 quarters. The position peaked at $6.14M in Q4 2023. 732 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

  • UBS O'Connor reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 34,144 Sanofi shares in Q4 2024, an estimated $1.97M.
  • UBS O'Connor first reported a position in Sanofi in Q2 2022 and held it in 10 quarters.
  • UBS O'Connor's Sanofi position peaked at $6.14M in Q4 2023.
  • 732 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.